Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 74,000 shares at $53.17 ($3.9M) on 2023-11-14, disclosed to the SEC on 2023-11-20.
Scheduled sale ($3.9M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.17 | 22,905 | $1.2M | 31.0% |
| 2 | $53.17 | 22,905 | $1.2M | 31.0% |
| 3 | $53.64 | 7,647 | $410K | 10.5% |
| 4 | $53.64 | 7,647 | $410K | 10.5% |
| 5 | $51.66 | 6,448 | $333K | 8.5% |
| 6 | $51.66 | 6,448 |
| $333K |
| 8.5% |
| Total | $53.00 avg | 74,000 | $3.9M | 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |